{"id":16587,"date":"2014-06-04T00:00:00","date_gmt":"2014-06-04T04:00:00","guid":{"rendered":"https:\/\/genomequebec.com\/actualites-et-publications\/genome-quebec-is-proud-to-recognize-a-major-investment-by-amorchem-for-acute-myeloid-leukemia\/"},"modified":"2014-06-04T00:00:00","modified_gmt":"2014-06-04T04:00:00","slug":"genome-quebec-is-proud-to-recognize-a-major-investment-by-amorchem-for-acute-myeloid-leukemia","status":"publish","type":"post","link":"https:\/\/genomequebec.com\/en\/news-and-publications\/genome-quebec-is-proud-to-recognize-a-major-investment-by-amorchem-for-acute-myeloid-leukemia\/","title":{"rendered":"G\u00e9nome Qu\u00e9bec is proud to recognize a major investment by AmorChem for Acute Myeloid Leukemia"},"content":{"rendered":"<p><span>AmorChem investment of $1.5 million will serve to develop new diagnostic and prognostic tools for acute myeloid leukemia (AML) patients to predict how they should be treated based on the genetic make-up of their tumor.\u00a0<\/span><\/p>\n<p><span><br \/><\/span><\/p>\n<p>This funding is part of a multi-institution initiative led by <a href=\"http:\/\/www.iric.ca\/en\/research\/principal-investigators\/guy-sauvageau\/?section=cv\" target=\"_blank\" rel=\"noopener\">Dr. Guy Sauvageau<\/a>, Chief Executive Officer and Principal Investigator of the Institute for Research and Immunology and Cancer (IRIC) at the Universit\u00e9 de Montr\u00e9al and by <a href=\"http:\/\/recherche.maisonneuve-rosemont.org\/en-ca\/research\/our-research-investigators\/hebert-josee.html\" target=\"_blank\" rel=\"noopener\">Dr. Jos\u00e9e H\u00e9bert<\/a>, Associate Investigator at IRIC and Director of the Qu\u00e9bec Leukemia Cell Bank and hematologist at Maisonneuve-Rosemont Hospital.<\/p>\n<p><span>This project received more than $11 million in funding through the Competition on Personalized Health of Genome Canada and G\u00e9nome Qu\u00e9bec in partnership with the Canadian Institutes of Health Research. Please see\u00a0<\/span><a href=\"http:\/\/www.iric.ca\/en\/2013\/04\/two-iric-researchers-stand-out-in-the-genomics-and-personalized-health-competition-of-genome-canadagenome-quebec\/\" target=\"_blank\" rel=\"noopener\">press release<\/a>\u00a0<span>posted on April 17, 2013.<\/span><\/p>\n<p><span style=\"font-size: 10px;\">\u00a0<\/span><\/p>\n<p><a href=\"http:\/\/www.iricor.ca\/amorchem-makes-1-5m-investment-to-develop-new-diagnostic-and-prognostic-tools-for-acute-myeloid-leukemia\/\" target=\"_blank\" rel=\"noopener\">Read the press release.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AmorChem investment of $1.5 million will serve to develop new diagnostic and prognostic tools for acute myeloid leukemia (AML) patients to predict how they should be treated based on the&hellip;<\/p>\n","protected":false},"author":1,"featured_media":15516,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[294],"tags":[],"class_list":["post-16587","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nouvelles"],"acf":[],"_links":{"self":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts\/16587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/comments?post=16587"}],"version-history":[{"count":0,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts\/16587\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/media\/15516"}],"wp:attachment":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/media?parent=16587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/categories?post=16587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/tags?post=16587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}